{"id":"iv-ceftriaxone","safety":{"commonSideEffects":[{"rate":"2-3%","effect":"Diarrhea"},{"rate":"1-2%","effect":"Rash"},{"rate":"1-2%","effect":"Phlebitis at injection site"},{"rate":"1%","effect":"Nausea"},{"rate":"1-3%","effect":"Hypersensitivity reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ceftriaxone works by disrupting the cross-linking of peptidoglycan in the bacterial cell wall, leading to cell wall instability and bacterial death. It has broad-spectrum activity against gram-positive and gram-negative bacteria, with enhanced activity against gram-negative organisms compared to earlier cephalosporin generations. The IV formulation allows for rapid systemic distribution and is commonly used for serious infections requiring parenteral therapy.","oneSentence":"Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:17:26.162Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Bacterial infections including meningitis, pneumonia, gonorrhea, and other serious gram-positive and gram-negative infections"},{"name":"Surgical prophylaxis"}]},"trialDetails":[{"nctId":"NCT07207876","phase":"","title":"Study of Ceftriaxone and Benzathine Penicillin G During Pregnancy","status":"RECRUITING","sponsor":"International Maternal Pediatric Adolescent AIDS Clinical Trials Group","startDate":"2026-02-16","conditions":"Pregnancy","enrollment":110},{"nctId":"NCT07485010","phase":"PHASE2","title":"Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Queensland","startDate":"2027-04","conditions":"Mycobacterium Abscessus Pulmonary Disease, Mycobacterium Abscessus Infection, Non-Tuberculous Mycobacterial (NTM) Infections","enrollment":300},{"nctId":"NCT06611111","phase":"EARLY_PHASE1","title":"Ceftriaxone Pulse Dose for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"State University of New York - Upstate Medical University","startDate":"2025-02-03","conditions":"Post-Treatment Lyme Disease","enrollment":44},{"nctId":"NCT06080698","phase":"NA","title":"Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-02-22","conditions":"Gram-negative Bacteremia","enrollment":1030},{"nctId":"NCT02701595","phase":"PHASE3","title":"Oral Switch During Treatment of Left-sided Endocarditis Due to Multi-susceptible Streptococcus","status":"COMPLETED","sponsor":"University Hospital, Tours","startDate":"2016-02-29","conditions":"Infective Endocarditis","enrollment":324},{"nctId":"NCT06785402","phase":"PHASE1, PHASE2","title":"Ceftriaxone for Post-Treatment Lyme Disease","status":"RECRUITING","sponsor":"Hackensack Meridian Health","startDate":"2026-02-15","conditions":"Post-Treatment Lyme Disease Syndrome","enrollment":20},{"nctId":"NCT06396078","phase":"PHASE4","title":"Improvement of PPROM Management With Prophylactic Antimicrobial Therapy (iPROMPT)","status":"RECRUITING","sponsor":"Ohio State University","startDate":"2024-07-18","conditions":"Preterm Premature Rupture of Membrane, Pregnancy, High Risk, Preterm Birth","enrollment":56},{"nctId":"NCT05074147","phase":"PHASE3","title":"Comparison Between Two Durations of Antibiotherapy for Non-surgically-treated Diabetic Foot Osteomyelitis (CHRONOS-2)","status":"WITHDRAWN","sponsor":"Tourcoing Hospital","startDate":"2022-05-01","conditions":"Osteomyelitis - Foot","enrollment":""},{"nctId":"NCT07332325","phase":"PHASE3","title":"STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis","status":"NOT_YET_RECRUITING","sponsor":"University of Virginia","startDate":"2026-04","conditions":"Sepsis, Tuberculosis","enrollment":344},{"nctId":"NCT05544565","phase":"PHASE4","title":"3-day IV Antibiotic Treatment Versus 3-day IV Followed by 7-day Oral Antibiotic Treatment for AP in Children","status":"RECRUITING","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2023-03-22","conditions":"Pyelonephritis Acute","enrollment":480},{"nctId":"NCT07318584","phase":"PHASE2","title":"Cefotetan Therapy for Escherichia Coli Infections","status":"NOT_YET_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2026-03","conditions":"E Coli Infection, ESBL Producing E.Coli","enrollment":84},{"nctId":"NCT05079620","phase":"PHASE4","title":"Early Antibiotics After Aspiration in ICU Patients","status":"TERMINATED","sponsor":"UConn Health","startDate":"2021-11-30","conditions":"Aspiration, Aspiration Pneumonia","enrollment":5},{"nctId":"NCT03012360","phase":"PHASE4","title":"Antimicrobial Treatment in Patients With Ventilator-associated Tracheobronchitis","status":"TERMINATED","sponsor":"University Hospital, Lille","startDate":"2018-02-08","conditions":"Mechanical Ventilation Complication, Critical Illness","enrollment":103},{"nctId":"NCT02473263","phase":"PHASE3","title":"Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2016-05-09","conditions":"Severe Septic Syndrome (Severe Sepsis and Septic Shock) Diagnosed and Treated by Mobile Intensive Care Unit","enrollment":398},{"nctId":"NCT03915366","phase":"PHASE2, PHASE3","title":"Empirical Treatment Against Cytomegalovirus and Tuberculosis in HIV-infected Infants With Severe Pneumonia","status":"COMPLETED","sponsor":"Hospital Universitario 12 de Octubre","startDate":"2020-03-01","conditions":"Pneumonia, HIV/AIDS, Tuberculosis","enrollment":563},{"nctId":"NCT03413384","phase":"PHASE2","title":"To Assess the Efficacy and Safety of Ceftriaxone in Patients With Mild to Moderate Parkinson's Disease Dementia","status":"ACTIVE_NOT_RECRUITING","sponsor":"BrainX Corporation","startDate":"2019-02-15","conditions":"Parkinson's Disease Dementia","enrollment":100},{"nctId":"NCT07148622","phase":"NA","title":"Effects of Different Antibiotic Regimens in Preterm Premature Rupture of Membranes","status":"COMPLETED","sponsor":"Yuzuncu Yil University","startDate":"2024-10-01","conditions":"Preterm Premature Rupture of Membranes (PPROM), Prophylaxis, Perinatal Outcomes","enrollment":40},{"nctId":"NCT03825874","phase":"","title":"Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children","status":"RECRUITING","sponsor":"Centre Hospitalier Intercommunal Creteil","startDate":"2019-01-19","conditions":"Urinary Tract Infections, Urinary Tract Infections in Children","enrollment":200},{"nctId":"NCT05121974","phase":"PHASE2","title":"Tebipenem Trial in Children With Shigellosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"International Centre for Diarrhoeal Disease Research, Bangladesh","startDate":"2022-08-18","conditions":"Shigellosis","enrollment":132},{"nctId":"NCT02996656","phase":"NA","title":"Antimicrobial Prophylaxis for Skin Colonization With Propionibacterium Acnes in Primary Open Shoulder Surgery","status":"RECRUITING","sponsor":"Université de Montréal","startDate":"2016-12","conditions":"Propionibacterium Infection","enrollment":88},{"nctId":"NCT05821478","phase":"PHASE3","title":"Efficacy of an Adapted Antibiotherapy in Hurley Stage 2 Hidradenitis Suppurativa Patients","status":"RECRUITING","sponsor":"Institut Pasteur","startDate":"2025-05-22","conditions":"Hidradenitis Suppurativa","enrollment":92},{"nctId":"NCT04999592","phase":"PHASE2","title":"Ceftriaxone to PRevent pneumOnia and inflammatTion aftEr Cardiac arresT (PROTECT)","status":"TERMINATED","sponsor":"David J. Gagnon","startDate":"2021-08-20","conditions":"Out-Of-Hospital Cardiac Arrest, Pneumonia","enrollment":53},{"nctId":"NCT04563325","phase":"PHASE4","title":"Oral-only Antibiotics for Bone and Joint Infections in Children","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2020-09-15","conditions":"Osteomyelitis, Septic Arthritis, Bone Infection","enrollment":180},{"nctId":"NCT06113939","phase":"NA","title":"Prevention of Infection of the Respiratory Tract Through Application of Non-Invasive Methods of Secretion Suctioning","status":"NOT_YET_RECRUITING","sponsor":"Hospital San Carlos, Madrid","startDate":"2025-05-19","conditions":"Intubation Complication, Stroke, Ischemic, Stroke Hemorrhagic","enrollment":60},{"nctId":"NCT06828952","phase":"","title":"Risk Factors of Failure of Conservative Treatment in Acute Non Complicated Appendicitis","status":"NOT_YET_RECRUITING","sponsor":"Ahmed Mohammed Hussein Sayed","startDate":"2025-06-22","conditions":"Conservative Management","enrollment":100},{"nctId":"NCT05849090","phase":"EARLY_PHASE1","title":"Vancomycin and Tobramycin Powder Use in Acute Open Fractures","status":"COMPLETED","sponsor":"University of Utah","startDate":"2023-03-27","conditions":"Infections","enrollment":10},{"nctId":"NCT05899140","phase":"PHASE4","title":"Adjunctive Clindamycin for the Treatment of Skin and Soft Tissue Infections, a Randomized Controlled Trial","status":"RECRUITING","sponsor":"Frieder Schaumburg","startDate":"2024-03-15","conditions":"Skin Infection, Staphylococcal Infections, Staphylococcus Aureus Infection","enrollment":100},{"nctId":"NCT06532409","phase":"NA","title":"Comparison of Efficacy of Oral Amoxicillin Versus Intravenous Ceftriaxone","status":"NOT_YET_RECRUITING","sponsor":"RESnTEC, Institute of Research","startDate":"2024-10-01","conditions":"Community-acquired Pneumonia","enrollment":114},{"nctId":"NCT02735707","phase":"PHASE3","title":"Randomized, Embedded, Multifactorial Adaptive Platform Trial for Community- Acquired Pneumonia","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2016-04-11","conditions":"Community-acquired Pneumonia, Influenza, COVID-19","enrollment":20000},{"nctId":"NCT04041791","phase":"PHASE3","title":"A Study to Compare Different Antibiotics and Different Modes of Fluid Treatment for Children With Severe Pneumonia","status":"COMPLETED","sponsor":"University of Oxford","startDate":"2019-08-19","conditions":"Pneumonia","enrollment":4392},{"nctId":"NCT05725226","phase":"NA","title":"Comparison Between 6Fr Vs 4Fr Double J Stent","status":"COMPLETED","sponsor":"Tribhuvan University, Nepal","startDate":"2023-04-07","conditions":"Renal Stone, Ureter Stone","enrollment":110},{"nctId":"NCT05724628","phase":"PHASE1","title":"Non-operative vs. Operative Management of Acute Appendicitis in Vulnerable Patient Populations","status":"WITHDRAWN","sponsor":"University of Texas Southwestern Medical Center","startDate":"2023-10","conditions":"Acute Appendicitis","enrollment":""},{"nctId":"NCT05925140","phase":"PHASE1","title":"LUSZ Treatment Efficacy in Hospitalized COVID-19 Patients","status":"UNKNOWN","sponsor":"Lebanese University","startDate":"2020-03-28","conditions":"COVID-19, Hospitalized COVID-19 Patients","enrollment":1000},{"nctId":"NCT05156437","phase":"PHASE4","title":"Postoperative Antibiotic Management Duration Following Surgery for Intravenous Drug Abuse (IVDA) Endocarditis (OPTIMAL)","status":"ENROLLING_BY_INVITATION","sponsor":"Vinay Badhwar","startDate":"2022-03-16","conditions":"Endocarditis","enrollment":20},{"nctId":"NCT05742139","phase":"","title":"Impact on the Quality of Life and Persistent Symptoms of Patients Away From Diagnosed and Treated Neuroborreliosis","status":"COMPLETED","sponsor":"Hopital Nord Franche-Comte","startDate":"2023-02-27","conditions":"Neuroborreliosis, Lyme, Quality of Life","enrollment":159},{"nctId":"NCT02389036","phase":"PHASE3","title":"Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients","status":"COMPLETED","sponsor":"The George Institute","startDate":"2017-05-01","conditions":"Critical Illness, Sepsis, Septic Shock","enrollment":20010},{"nctId":"NCT05943223","phase":"PHASE2","title":"Piperacillin/Tazobactam Versus ceftriAxone and Metronidazole for Children With Perforated Appendicitis (ALPACA)","status":"UNKNOWN","sponsor":"McMaster Children's Hospital","startDate":"2024-01","conditions":"Appendicitis Perforated","enrollment":16},{"nctId":"NCT03439124","phase":"PHASE3","title":"Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia","status":"COMPLETED","sponsor":"Basilea Pharmaceutica","startDate":"2017-11-27","conditions":"Community-acquired Pneumonia (CAP), Hospital-acquired Pneumonia (HAP)","enrollment":138},{"nctId":"NCT02800785","phase":"NA","title":"The Comparison of Outcomes of Antibiotic Drugs and Appendectomy (CODA) Trial","status":"COMPLETED","sponsor":"University of Washington","startDate":"2016-05","conditions":"Appendicitis","enrollment":1552},{"nctId":"NCT05747807","phase":"NA","title":"Percutaneous Intradiscal Radiofrequency as A Treatment for Radicular Pain From Lumbar Disc Herniation","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2023-04-01","conditions":"Disk Herniated Lumbar, Radicular Pain, Intradiscal Radiofrequency","enrollment":18},{"nctId":"NCT05666973","phase":"NA","title":"To Compare the Skin Incision Made by the Electrocautery and Scalpel in Inguinal Hernia Repair","status":"UNKNOWN","sponsor":"Tribhuvan University Teaching Hospital, Institute Of Medicine.","startDate":"2023-01","conditions":"Post-operative Pain, Acute","enrollment":60},{"nctId":"NCT00591318","phase":"PHASE1, PHASE2","title":"A Placebo-controlled Efficacy Study of IV Ceftriaxone for Refractory Psychosis","status":"TERMINATED","sponsor":"Research Foundation for Mental Hygiene, Inc.","startDate":"2007-10-10","conditions":"Psychosis, Schizophrenia, Schizoaffective Disorder","enrollment":12},{"nctId":"NCT05511194","phase":"NA","title":"Safety and Efficacy of ERAS Therapeutic Protocol for Complicated Appendicitis in Children","status":"UNKNOWN","sponsor":"Instituto Mexicano del Seguro Social","startDate":"2022-10-01","conditions":"Enhanced Recovery After Surgery, Appendicitis, Children, Only","enrollment":40},{"nctId":"NCT05417997","phase":"PHASE3","title":"Effect of Kunamin in SARS-CoV-2 RT-PCR Positive Covid-19 Patients","status":"COMPLETED","sponsor":"RAAS Nutritionals, LLC","startDate":"2021-05-29","conditions":"COVID-19 Respiratory Infection, FLU, Cold; Influenza","enrollment":71},{"nctId":"NCT05216744","phase":"PHASE2","title":"Comparison of Efficacy of Two Combination Regimens for the Neisseria Gonorrhoeae and Chlamydia Coinfection","status":"COMPLETED","sponsor":"Haiphong University of Medicine and Pharmacy","startDate":"2021-07-15","conditions":"Neisseria Gonorrhoeae Infection, Chlamydia Trachomatis Infection","enrollment":125},{"nctId":"NCT02099240","phase":"EARLY_PHASE1","title":"Patients Response to Early Switch To Oral:Osteomyelitis Study","status":"TERMINATED","sponsor":"Julio Ramirez","startDate":"2014-03-06","conditions":"Osteomyelitis","enrollment":11},{"nctId":"NCT00462020","phase":"NA","title":"Intravenous Versus Intravenous/Oral Antibiotics for Perforated Appendicitis","status":"COMPLETED","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2007-03","conditions":"Perforated Appendicitis","enrollment":102},{"nctId":"NCT03583749","phase":"","title":"Pharmacokinetics and Safety of Antimicrobial Agents Administered by Subcutaneous Route in Patients AGEd Over 65 Years","status":"UNKNOWN","sponsor":"University Hospital, Bordeaux","startDate":"2019-08-07","conditions":"Antimicrobials, Subcutaneous Injection, Antibiotic","enrollment":150},{"nctId":"NCT00161330","phase":"PHASE3","title":"Oral vs Initial Intravenous Antibiotic Treatment of Urinary Tract Infections in Children: a RCT","status":"TERMINATED","sponsor":"University of Padova","startDate":"2000-06","conditions":"Urinary Tract Infections","enrollment":440},{"nctId":"NCT03794765","phase":"PHASE2","title":"Antibiotics as an Adjuvant in Patients With Acute Severe Ulcerative Colitis","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2019-04-01","conditions":"Ulcerative Colitis, Inflammatory Bowel Diseases, Acute Severe Colitis","enrollment":50},{"nctId":"NCT03560232","phase":"PHASE4","title":"Noninferiority Comparison of Prophylactic Open Fracture Antimicrobial Regimens","status":"TERMINATED","sponsor":"Mercy Health Ohio","startDate":"2018-07-09","conditions":"Open Fracture, Post-Op Wound Infection","enrollment":17},{"nctId":"NCT02795949","phase":"PHASE3","title":"Study on Reduced Antibiotic Treatment vs Broad Spectrum Betalactam in Patients With Bacteremia by Enterobacteriaceae","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2016-10","conditions":"Enterobacteriaceae Infections","enrollment":344},{"nctId":"NCT04347512","phase":"PHASE3","title":"EVALUATION OF THE EFFICACY OF THE HYDROXYCHLOROQUINE-AZITHROMYCIN COMBINATION IN THE IN THE PREVENTION OF COVID-19 RELATED SDRA","status":"WITHDRAWN","sponsor":"University Hospital, Strasbourg, France","startDate":"2020-06-02","conditions":"Sars-CoV-2, Community-Acquired Pneumonia,COVID-19","enrollment":""},{"nctId":"NCT03174236","phase":"PHASE3","title":"First Line Antimicrobials in Children With Complicated Severe Acute Malnutrition","status":"UNKNOWN","sponsor":"University of Oxford","startDate":"2017-09-04","conditions":"Malnutrition Severe, Antibiotic Resistance, Antibiotic Toxicity","enrollment":2000},{"nctId":"NCT01265173","phase":"PHASE4","title":"Comparison of Efficacy of Cefotaxime, Ceftriaxone, and Ciprofloxacin for the Treatment of SBP in Patients With LC","status":"COMPLETED","sponsor":"Korea University","startDate":"2007-04","conditions":"SBP, Liver Cirrhosis","enrollment":261},{"nctId":"NCT00566111","phase":"NA","title":"Ceftriaxone in the Management of Bipolar Depression","status":"TERMINATED","sponsor":"Yale University","startDate":"2007-09","conditions":"Bipolar Depression","enrollment":5},{"nctId":"NCT04202068","phase":"PHASE4","title":"A Study Evaluating Efficacy and Safety of CRO-SBT in the Treatment of Gonorrhea","status":"COMPLETED","sponsor":"Xiangbei Welman Pharmaceutical Co., Ltd","startDate":"2015-07-03","conditions":"Gonorrhea","enrollment":113},{"nctId":"NCT04141787","phase":"PHASE4","title":"Ceftriaxone as Home IV for Staph Infections","status":"UNKNOWN","sponsor":"Vancouver Island Health Authority","startDate":"2019-07-11","conditions":"Staphylococcal Infections, Osteomyelitis, CNS Infection","enrollment":310},{"nctId":"NCT03477422","phase":"PHASE3","title":"CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) Caused by ESBL Producing Gram Negative Bacteria","status":"COMPLETED","sponsor":"Venus Remedies Limited","startDate":"2014-01-11","conditions":"Urinary Tract Infection Complicated, Acute Pyelonephritis","enrollment":230},{"nctId":"NCT04066621","phase":"PHASE4","title":"PHase IV Clinical Trial of Ceftriaxone Sodium and Sulbactam Sodium for Injection (CRO-SBT)","status":"COMPLETED","sponsor":"Xiangbei Welman Pharmaceutical Co., Ltd","startDate":"2015-04-28","conditions":"Respiratory Tract Infections, Urinary Tract Infections in Children","enrollment":30},{"nctId":"NCT02384200","phase":"PHASE4","title":"A Randomized Trial of Preoperative Prophylactic Antibiotics Prior to Kidney Stone Surgery (Percutaneous Nephrolithotomy [PCNL])","status":"COMPLETED","sponsor":"University of California, San Diego","startDate":"2015-03","conditions":"Nephrolithiasis, Urinary Tract Infections","enrollment":86},{"nctId":"NCT02142751","phase":"PHASE3","title":"Fosfomycin Versus Meropenem or Ceftriaxone in Bacteriemic Infections Caused by Multidrug Resistance in E.Coli","status":"COMPLETED","sponsor":"Fundación Pública Andaluza para la gestión de la Investigación en Sevilla","startDate":"2014-07","conditions":"Infection Due to ESBL Escherichia Coli","enrollment":161},{"nctId":"NCT01756924","phase":"PHASE2","title":"Safety and Efficacy of CEM-102 With Rifampin Compared to Standard Therapy in Patients With Prosthetic Joint Infections or Spacer Infection","status":"TERMINATED","sponsor":"Arrevus Inc.","startDate":"2012-12","conditions":"Prosthetic Joint Infections of Hip, Prosthetic Joint Infections of Knee, Infected Spacers","enrollment":14},{"nctId":"NCT02419001","phase":"PHASE1, PHASE2","title":"A Study to Evaluate the Effect of SYN-004 on the PK of IV Ceftriaxone in Adults With a Functioning Ileostomy","status":"COMPLETED","sponsor":"Theriva Biologics, Inc.","startDate":"2015-03","conditions":"Healthy Volunteers","enrollment":11},{"nctId":"NCT03518463","phase":"NA","title":"Enhanced Recovery After Surgery for Emergency Caesarean Deliveries","status":"COMPLETED","sponsor":"Mbarara University of Science and Technology","startDate":"2017-06-20","conditions":"Pregnancy Related","enrollment":160},{"nctId":"NCT03449940","phase":"NA","title":"Penile Fracture: A Comparison of Erectile Function After Immediate Repair Versus Delayed Repair","status":"COMPLETED","sponsor":"Ministry of Health, Jamaica","startDate":"2015-01","conditions":"Erectile Dysfunction","enrollment":46},{"nctId":"NCT02176122","phase":"PHASE4","title":"RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.","status":"TERMINATED","sponsor":"The University of Queensland","startDate":"2014-02","conditions":"Bloodstream Infections","enrollment":391},{"nctId":"NCT01371838","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of Intravenous Ceftaroline Versus Intravenous Ceftriaxone in the Treatment of Adult Hospitalised Patients With Community-Acquired Bacterial Pneumonia in Asia","status":"COMPLETED","sponsor":"Pfizer","startDate":"2011-12","conditions":"Community-Acquired Bacterial Pneumonia, Lung Infection of Individual Not Recently Hospitalized","enrollment":848},{"nctId":"NCT03245879","phase":"NA","title":"Antibiotic Stewardship in Small Hospitals","status":"COMPLETED","sponsor":"Intermountain Health Care, Inc.","startDate":"2013-07","conditions":"Inappropriate Prescribing, Antibiotic Stewardship, Anti-Bacterial Agents","enrollment":30000},{"nctId":"NCT02561442","phase":"PHASE2, PHASE3","title":"Crossover Study to Compare the Pharmacokinetics of Subcutaneous and Intravenous Ceftriaxone Administration","status":"COMPLETED","sponsor":"scPharmaceuticals, Inc.","startDate":"2015-10","conditions":"Pharmacokinetics in Healthy Adults","enrollment":18},{"nctId":"NCT01014013","phase":"PHASE3","title":"Safety and Tolerability of Ertapenem Sodium in the Treatment of Complicated Urinary Tract Infections (0826-055)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2008-04","conditions":"Urinary Tract Infection","enrollment":271},{"nctId":"NCT01254344","phase":"PHASE3","title":"Efficacy and Safety of Ertapenem Sodium (MK-0826) Following Colorectal Surgery in Chinese Adults (MK-0826-056)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2010-12","conditions":"Infection, Surgical Site Infection","enrollment":599},{"nctId":"NCT00509106","phase":"PHASE3","title":"Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2007-07","conditions":"Bacterial Pneumonia","enrollment":622},{"nctId":"NCT00621504","phase":"PHASE3","title":"Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2008-01","conditions":"Bacterial Pneumonia","enrollment":606},{"nctId":"NCT00035347","phase":"PHASE4","title":"Intravenous Azithromycin Plus Intravenous Ceftriaxone Followed by Oral Azithromycin With Intravenous Levofloxacin Followed by Oral Levofloxacin for the Treatment of Moderate to Severely Ill Hospitalized Patients With Community Acquired Pneumonia","status":"COMPLETED","sponsor":"Pfizer","startDate":"2001-01","conditions":"Community-Acquired Pneumonia (CAP)","enrollment":219},{"nctId":"NCT00111644","phase":"PHASE2","title":"A Study to Assess Beta-Lactam in the Treatment of Hospitalized Patients With Bacterial Pneumonia","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2005-03","conditions":"Pneumonia, Bacterial","enrollment":302},{"nctId":"NCT02742948","phase":"PHASE2","title":"The Optimal Time for Intravenous Antibiotic Prophylaxis in Elective Cesarean Section","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2016-04","conditions":"Endometritis","enrollment":600},{"nctId":"NCT02736682","phase":"PHASE4","title":"Single Dose Ceftriaxone and Metronidazole Versus Multiple Doses for Antibiotic Prophylaxis at Elective Cesarean Section.","status":"COMPLETED","sponsor":"Makerere University","startDate":"2015-09","conditions":"Post Operative Infections","enrollment":174},{"nctId":"NCT00797108","phase":"PHASE2","title":"A Study Of Intravenous Sulopenem And Oral PF-03709270 In Community Acquired Pneumonia That Requires Hospitalization","status":"COMPLETED","sponsor":"Pfizer","startDate":"2009-01","conditions":"Pneumonia, Bacterial","enrollment":35},{"nctId":"NCT01645735","phase":"PHASE4","title":"Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2012-10","conditions":"Infections","enrollment":49},{"nctId":"NCT00895089","phase":"PHASE4","title":"Moxifloxacin Versus Ceftriaxone in the Treatment of Primary Pyogenic Liver Abscess","status":"COMPLETED","sponsor":"Kaohsiung Veterans General Hospital.","startDate":"2009-05","conditions":"Liver Abscess","enrollment":24},{"nctId":"NCT01669980","phase":"PHASE4","title":"Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Complicated Community Acquired Pneumonia (CABP)","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2012-10","conditions":"Infections, Pneumonia","enrollment":40},{"nctId":"NCT00838864","phase":"PHASE4","title":"Comparison of 3 Days and 7 Days Intravenous Ceftriaxone Prophylaxis for Variceal Bleeding","status":"COMPLETED","sponsor":"Far Eastern Memorial Hospital","startDate":"2009-03","conditions":"Esophageal and Gastric Varices, Gastrointestinal Hemorrhage","enrollment":79},{"nctId":"NCT01530763","phase":"PHASE2, PHASE3","title":"Safety and Efficacy Study of Ceftaroline Versus a Comparator in Pediatric Subjects With Community Acquired Bacterial Pneumonia (CABP)","status":"COMPLETED","sponsor":"Forest Laboratories","startDate":"2012-09","conditions":"Infections, Community Acquired Pneumonia","enrollment":161},{"nctId":"NCT00431678","phase":"PHASE3","title":"Efficacy and Safety of Sequential IV/PO Moxifloxacin in Comparison to IV Levofloxacin Plus IV Ceftriaxone Followed by PO Levofloxacin, in the Treatment of Patients With Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2004-01","conditions":"Pneumonia","enrollment":738},{"nctId":"NCT00717561","phase":"PHASE3","title":"A Study to Assess the Efficacy and Safety of IV/PO Moxifloxacin in Subjects With Community-acquired Pneumonia","status":"COMPLETED","sponsor":"Bayer","startDate":"2008-02","conditions":"Pneumonia","enrollment":60},{"nctId":"NCT01757236","phase":"PHASE2","title":"Efficacy and Safety Study of Antibiotic Treatment to Treat Hip Prosthetic Joint Infection","status":"UNKNOWN","sponsor":"University Hospital, Tours","startDate":"2012-10","conditions":"Hip Prosthetic Joint Infection","enrollment":100},{"nctId":"NCT02123628","phase":"PHASE4","title":"Antibiotic Treatment Duration for Non-Surgically-Treated Diabetic Foot Osteomyelitis","status":"COMPLETED","sponsor":"Tourcoing Hospital","startDate":"2007-06","conditions":"Diabetes Mellitus","enrollment":40},{"nctId":"NCT00230971","phase":"PHASE4","title":"Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection (cIAI)","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-10","conditions":"Appendicitis, Cholecystitis, Diverticulitis","enrollment":473},{"nctId":"NCT00195351","phase":"PHASE4","title":"Study Comparing Tigecycline Versus Ceftriaxone Sodium Plus Metronidazole in Complicated Intra-abdominal Infection","status":"COMPLETED","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2005-09","conditions":"Appendicitis, Cholecystitis, Cross Infection","enrollment":467},{"nctId":"NCT01602874","phase":"PHASE3","title":"Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia","status":"WITHDRAWN","sponsor":"Pfizer","startDate":"2011-01","conditions":"Community Acquired Bacterial Pneumonia, Complicated Intra-Abdominal Infection","enrollment":""},{"nctId":"NCT00914888","phase":"PHASE3","title":"Study Evaluating Tigecycline Versus Ceftriaxone In Complicated Intra-Abdominal Infections & Community Acquired Pneumonia","status":"WITHDRAWN","sponsor":"Wyeth is now a wholly owned subsidiary of Pfizer","startDate":"2011-01","conditions":"Community Acquired Bacterial Pneumonia, Complicated Intra-Abdominal Infection","enrollment":""},{"nctId":"NCT00493220","phase":"PHASE1","title":"Pharmacokinetic and Safety Study of HYLENEX Recombinant-Augmented Subcutaneous Ceftriaxone Administration","status":"COMPLETED","sponsor":"Baxter Healthcare Corporation","startDate":"2007-06","conditions":"Healthy","enrollment":30},{"nctId":"NCT00942006","phase":"NA","title":"Doxycycline and Ceftriaxone in Suspected Early Lyme Neuroborreliosis","status":"UNKNOWN","sponsor":"University Medical Centre Ljubljana","startDate":"2009-07","conditions":"Suspected Early Lyme Neuroborreliosis","enrollment":200},{"nctId":"NCT00136656","phase":"PHASE4","title":"Treatment of Acute Pyelonephritis With Gram Negative Strains in Infants and Children Less Than 3 Years Old","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2005-07","conditions":"Pyelonephritis","enrollment":700}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["ceftriaxone","Ceftriaxone"],"phase":"phase_3","status":"active","brandName":"IV ceftriaxone","genericName":"IV ceftriaxone","companyName":"RESnTEC, Institute of Research","companyId":"resntec-institute-of-research","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ceftriaxone is a third-generation cephalosporin antibiotic that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins. Used for Bacterial infections including meningitis, pneumonia, gonorrhea, and other serious gram-positive and gram-negative infections, Surgical prophylaxis.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}